An opinion on the IP of EX1, page-8

Hi Liam,

I have referred to the prospectus section 8 for Patent Attorney’s Report for information on Exopharm’s patent application. It’s all clearly there including risk statements, there are no guarantees, however reports have been positive that Exopharm do have novel IP in claims, so their process excluding claim 1 and then 15-17. So all in between in their process of extracting exosomes. It’s possible this is what has been updated in the claim for IP?

This was clearly an update on the application, that was initially dated 3/1/19, but now dated the 5/1/19. & at the bottom of the page a declaration regarding USA. I’m not a patently minded person, nor have a legal background, so can only do my best to understand it all. I have every faith in Dr Dixon & his team & It’s not a new application.

Hopefully we will get an ANN soon on any major developments, particularly if the patent is granted. That will be massive news for Exopharm. IMO & DYOR GLTAH .